This Week in Psychedelics - 1.14.22

Cannabis

  • Oregon State research shows hemp compounds prevent coronavirus from entering human cells (Oregon State University)

  • Polls Funded By Marijuana Prohibitionist Group Show Big Support For Legalization Policies It Lobbies Against (Marijuana Moment)

  • Top German Government Official Previews Marijuana Legalization Plan Details (Marijuana Moment)

  • First-dose vaccinations quadruple in Quebec ahead of restrictions at liquor and cannabis stores (CTV News)

  • Mississippi Senate Votes To Legalize Medical Marijuana, Defying Governor’s Veto Threat (Marijuana Moment)

  • Oregon: New Rules Increase the Amount of Cannabis Adults Can Purchase Per Transaction (NORML)

  • Ohio Marijuana Activists Turn In More Signatures For Legalization Initiative After Temporary Setback (Marijuana Moment)

  • Delaware Lawmakers File New Marijuana Legalization Bill With Key Equity Revisions (Marijuana Moment)

  • Kansas lawmaker wants to refer medical marijuana legalization to voters (Marijuana Business Daily)

  • Austin Officials Certify Local Marijuana Decriminalization Initiative For May Ballot (Marijuana Moment)

  • Wyoming Activists Prepare Cannabis Reform Initiatives (High Times)

  • Virginia Lawmakers Divided On Releasing Marijuana Prisoners Following Legalization Taking Effect (Marijuana Moment)

  • South Dakota Governor Wants Marijuana Activists To Pay Legal Bill For Her Lawsuit That Blocked Legalization (Marijuana Moment)

  • Florida Marijuana Activists Pivot To 2024 For Legalization Ballot Initiative (Marijuana Moment)

Magic Mushrooms

  • Global Coalition Launches Push To Reschedule Psilocybin Under International Rules (Marijuana Moment)

  • Italian Officials Certify Signatures For National Marijuana And Psilocybin Referendum (Marijuana Moment)

  • Rollups: The Emerging Magic Mushroom Monopoly (The American Prospect)

  • Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product (Psilocybin Alpha)

  • Psilocybin Clinical Trial for Depression Launches at Pacific Neuroscience Institute (PR Newswire)

MDMA

  • MAPS Publishes Open Science Approach to Synthesizing MDMA (Lucid News)

Ayahuasca

  • A New Study Attempts To Quantify The Healing Powers Of Ayahuasca (Forbes)

Novel Psychoactive Substances

  • Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development Enabling Quick Screening of Billions of Compounds (Psilocybin Alpha)

  • Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development (Psilocybin Alpha)

Ketamine

  • Trial of Ketamine Therapy for Alcohol Use Disorder Reports Positive Findings (Technology Networks)

  • Osmind Announces Publication of the Largest Real-World Analysis of Ketamine Infusion Therapy for Depression (Business Wire)

  • Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel Flow Technology to Measure Psychedelic Effects on the Brain (Psilocybin Alpha)

  • Peter Thiel-Backed Psychedelics Company Gets FDA Approval To Study Ketamine Therapy (Forbes)

  • PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS (Psilocybin Alpha)

Miscellaneous

  • How Beer and Drugs Empowered an Ancient Andean Empire (Gizmodo)

  • These States Could Legalize Marijuana Or Psychedelics In 2022 (Marijuana Moment)

  • Virginia Could Decriminalize Psilocybin And Other Psychedelics With Newly Filed Bills (Marijuana Moment)

  • Social Media Attacks and Ethical Issues in the Psychedelic Sector — Why can’t we all get on together for the greater good? (Medium)

  • Missouri Patients Could Use Psychedelic Treatments Under New GOP ‘Right-To-Try’ Bill (Marijuana Moment)

  • ‘Microdosers’ of LSD and magic mushrooms are wiser and more creative (Daily Maverick)

  • Promising Psychedelic Therapy Legislation Set to Make Waves in 2022 (Psychedelic Spotlight)

  • Vermont Lawmakers File Drug Decriminalization Bill With Hopes Of Promoting Harm Reduction (Marijuana Moment)

  • Announcing a Major Healthy Persons Trial to Investigate the Brain Activity Effects of Psychedelic Medicines (Mind Medicine Australia)

  • University Of Ottawa To Offer Psychedelic Studies Master’s Program Beginning In Fall 2022 (Healing Maps)

  • The Connection between Psychedelics and Christianity (The Institute for the Advancement of Psychedelic Christianity)

  • Metaphysical Insight: Psychedelics, Noetic Experiences, and Spinoza’s God (Sam Woolfe)

  • How to Come Out to Your Kids About Psychedelics (DoubleBlind)

  • Psychedelics in Healthcare: The Psychedelic Pharmacists Association (Truffle Report)

  • Can Western Medicine Include the Sacred in Psychedelic-Assisted Psychotherapy? (Lucid News)

  • How To Vet Your Psychedelic Guide (DoubleBlind)

  • Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted Psychotherapy For Patients (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.